| Engineering intravenously administered nanoparticles to reduce infusion reaction and stop bleeding in a large animal model of trauma C Onwukwe, N Maisha, M Holland, M Varley, R Groynom, DS Hickman, ... Bioconjugate chemistry 29 (7), 2436-2447, 2018 | 31 | 2018 |
| The chemistry of lyophilized blood products J Fernandez-Moure, N Maisha, EB Lavik, JW Cannon Bioconjugate chemistry 29 (7), 2150-2160, 2018 | 20 | 2018 |
| A non-invasive nanoparticle-based sustained dual-drug delivery system as an eyedrop for endophthalmitis B Mahaling, N Baruah, N Ahamad, N Maisha, E Lavik, DS Katti International Journal of Pharmaceutics 606, 120900, 2021 | 16 | 2021 |
| Development of a sensitive assay to screen nanoparticles in vitro for complement activation N Maisha, T Coombs, E Lavik ACS biomaterials science & engineering 6 (9), 4903-4915, 2020 | 13 | 2020 |
| Engineering PEGylated polyester nanoparticles to reduce complement-mediated infusion reaction N Maisha, N Naik, M Okesola, T Coombs, R Zilberberg, N Pandala, ... Bioconjugate Chemistry 32 (10), 2154-2166, 2021 | 11 | 2021 |
| Removal of heavy metal from industrial effluents using Baker’s yeast A Ferdous, N Maisha, N Sultana, S Ahmed AIP Conference Proceedings 1754 (1), 2016 | 11 | 2016 |
| Getting to the core of it all: nanocapsules to mitigate infusion reactions can promote hemostasis and be a platform for intravenous therapies N Maisha, M Rubenstein, CJ Bieberich, E Lavik Nano letters 21 (21), 9069-9076, 2021 | 6 | 2021 |
| PEGylated Polyester Nanoparticles Trigger Adverse Events in a Large Animal Model of Trauma and in Naı̈ve Animals: Understanding Cytokine and Cellular Correlations with These Events N Maisha, C Kulkarni, N Pandala, R Zilberberg, L Schaub, L Neidert, ... ACS nano 16 (7), 10566-10580, 2022 | 5 | 2022 |
| Risk map for facility siting of an ammonia-urea complex SR Syeda, N Maisha, A Ferdous Journal of Chemical Engineering 29 (1), 56-60, 2017 | 4 | 2017 |
| Computational Design Map for Heterogeneous Experimental Studies C Kulkarni, N Maisha, LJ Schaub, J Glaser, E Lavik, VP Janeja bioRxiv, 2021.05. 25.445627, 2021 | 1 | 2021 |
| Nanocapsules with HIF-1-alpha Inhibitor for Treatment of Choroidal Neovascularization in a Rat Model I Han, N Pandala, N Maisha, T Ale, R Mullins, EB Lavik, BA Tucker Investigative Ophthalmology & Visual Science 64 (8), 2613-2613, 2023 | | 2023 |
| Hemostatic nanocapsules for stopping bleeding, visualizing injury, and delivering drugs E Lavik, N Maisha US Patent App. 17/812,746, 2023 | | 2023 |
| Temporal Progression: A case study in Porcine Survivability through Hemostatic Nanoparticles C Kulkarni, N Maisha, LJ Schaub, J Glaser, E Lavik, VP Janeja bioRxiv, 2021.05. 25.445617, 2021 | | 2021 |
| Developing Stealth Nanomaterials for Intravenous Administration to Overcome Complement-Mediated Hypersensitivity Reactions N Maisha University of Maryland, Baltimore County, 2021 | | 2021 |
| Facility Siting of an Ammonia-Urea Complex Based on Risk Analysis N Maisha, A Ferdous, SR Syeda Mary K O'Connor Process Safety Symposium. Proceedings 2015., 2015 | | 2015 |
| Computational Design Map for Heterogeneous Experimental Studies C Kulkarni, N Maisha, LJ Schaub, J Glaser, E Lavik, V Janeja Frontiers in Big Data, 111, 0 | | |
